MMSI
Merit Medical Systems Inc.
$90.54
+$0.49(+0.54%)
46
Overall
65
Value
27
Tech
--
Quality
Market Cap
$5.27B
Volume
366.26K
52W Range
$81.04 - $111.45
Target Price
$104.36
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $994.9M | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | ||
| Total Revenue | $994.9M | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $562.5M | $562.7M | $589.4M | $631.9M | $673.5M | $713.2M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $432.4M | $401.2M | $485.3M | $519.1M | $583.9M | $643.3M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $416.9M | $402.7M | $424.4M | $424.7M | $459.9M | $487.6M | ||
| Research & Development | $66.1M | $57.8M | $71.2M | $82.2M | $84.3M | $87.5M | ||
| Research Expense | $65.6M | $57.5M | $71.2M | $75.5M | $82.7M | $87.5M | ||
| Selling, General & Administrative | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | ||
| General & Administrative Expenses | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | ||
| Salaries & Wages | -- | -- | -- | $18.0M | $21.3M | $28.5M | ||
| Depreciation & Amortization | $92.1M | $94.1M | $84.1M | $81.8M | $90.0M | $102.7M | ||
| Depreciation & Amortization | $92.1M | $94.1M | $84.1M | $81.8M | $90.0M | $102.7M | ||
| Amortization | $353.2M | $363.5M | $361.7M | $359.8M | $382.2M | $463.5M | ||
| Other Operating Expenses | $232.0K | $8.0M | $-3.2M | $-294.0K | $-442.0K | $-559.0K | ||
| OPERATING INCOME | ||||||||
| Operating income | $15.4M | $-1.6M | $60.9M | $87.6M | $123.9M | $155.7M | ||
| EBITDA | $107.4M | $103.6M | $155.0M | $181.8M | $215.1M | $271.5M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $12.4M | $10.0M | $5.3M | $6.3M | $15.5M | -- | ||
| Net Non-Operating Interest Income/Expense | $-12.4M | $-10.0M | $-5.3M | $5.9M | $-287.0K | $-798.0K | ||
| Gain on Sale of Securities | $-291.0K | $604.0K | $769.0K | $439.0K | $2.5M | $26.2M | ||
| Other Income/Expense | $828.0K | $1.7M | $1.7M | $-5.9M | $-3.7M | $-25.5M | ||
| Other Special Charges | $-537.0K | $-2.3M | $-2.5M | $966.0K | $1.2M | $-711.0K | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | $2.7M | $3.1M | ||
| Special Income Charges | $-23.8M | $-55.2M | $-14.3M | $-2.2M | $-270.0K | $-3.1M | ||
| Impairment of Capital Assets | $23.8M | $36.5M | $4.3M | $2.2M | $270.0K | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $14.6M | $-3.2M | $59.2M | $89.0M | $112.1M | $150.0M | ||
| Pre-Tax Income | $2.2M | $-13.2M | $53.9M | $82.6M | $112.1M | $150.0M | ||
| INCOME TAX | ||||||||
| Tax Provision | $-3.3M | $-3.4M | $5.5M | $8.1M | $17.7M | $29.6M | ||
| NET INCOME | ||||||||
| Net Income | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | ||
| Net Income (Continuing Operations) | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | ||
| Net Income (Discontinued Operations) | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | ||
| Net Income (Common Stockholders) | $5.0M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | ||
| TOTALS | ||||||||
| Total Expenses | $979.4M | $965.4M | $1.0B | $1.1B | $1.1B | $1.2B | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $55.1M | $55.4M | $56.1M | $56.8M | $57.6M | $58.2M | ||
| Average Shares Outstanding (Diluted) | $56.2M | $55.4M | $57.4M | $57.7M | $58.4M | $59.4M | ||
| Shares Outstanding | $55.2M | $55.7M | $56.6M | $57.3M | $57.9M | $58.8M | ||
| Basic EPS | $0.10 | $-0.18 | $0.86 | $1.31 | $1.64 | $2.07 | ||
| Basic EPS (Continuing Operations) | $0.10 | $-0.18 | $0.86 | $1.31 | $1.64 | $2.07 | ||
| Diluted EPS | $0.10 | $-0.18 | $0.84 | $1.29 | $1.62 | $2.03 | ||
| Diluted EPS (Continuing Operations) | $0.10 | $-0.18 | $0.84 | $1.29 | $1.62 | $2.03 | ||
| OTHER METRICS | ||||||||
| Development Expense | $525.0K | $250.0K | -- | $6.7M | $1.6M | -- | ||
| Gain On Sale Of Business | -- | -- | -- | $-1.4M | $431.0K | -- | ||
| Non Recurring Operation Expense | -- | $18.7M | $10.0M | -- | -- | -- | ||
| Other Gand A | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | ||
| Other Impairment Of Capital Assets | $837.0K | $1.5M | $1.4M | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | $2.7M | $3.1M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MMSI | $90.54 | +0.5% | 366.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Merit Medical Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW